Andrew R. Tee

20.2k citations

69 papers · 9.1k indexed · 4 hit papers · h-index 39

Impact in

Molecular Biology top 0.5%
- PI3K/AKT/mTOR signaling in cancer
- Polyamine Metabolism and Applications
- Protein Kinase Regulation and GTPase Signaling
- Metabolism, Diabetes, and Cancer
Aging top 2%

Papers in

Molecular Biology 53
- PI3K/AKT/mTOR signaling in cancer 40
- Polyamine Metabolism and Applications 21
- Protein Kinase Regulation and GTPase Signaling 7
Physiology 18
- Tuberous Sclerosis Complex Research 17

Co-authors: John Blenis Lewis C. Cantley Brendan D. Manning Elaine A. Dunlop Christopher G. Proud Diane C. Fingar Stephen C. Land Kayleigh Dodd
Journals: Journal of Biological Chemistry (8 papers)Seminars in Cell and Developmental Biology (5 papers)Oncogene (5 papers)Cancers (4 papers)Cellular Signalling (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

Andrew R. Tee

68 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb 2003 · 949 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Current Biology
2003 Molecular and Cellular Biology
2002 Molecular Cell
2002 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Andrew R. Tee

Since Specialization

Citations

This map shows the geographic impact of Andrew R. Tee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew R. Tee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew R. Tee more than expected).

Fields of papers citing papers by Andrew R. Tee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew R. Tee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew R. Tee. The network helps show where Andrew R. Tee may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew R. Tee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew R. Tee Line = papers co-authored together Andrew R. Tee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tuberous Sclerosis Complex cell‐derived EVs have an altered protein cargo capable of regulating their microenvironment and have potential as disease biomarkers Journal of Extracellular Vesicles ·Muireann Ní Bhaoighill, Juan Manuel Falcón‐Pérez, Félix Royo, Andrew R. Tee, Jason Webber, Elaine A. Dunlop	2023	3
2	Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours British Journal of Cancer ·Silpa Gampala, Fenil Shah, Chi Zhang, Steven D. Rhodes, Olivia Babb, Michelle Grimard, Randall Wireman, Ellie Rad, Brian L. Calver, Ren-Yuan Bai, Verena Staedtke, Emily Hulsey, M. Reza Saadatzadeh, Karen E. Pollok, Yan Tong, Abbi E. Smith, D. Wade Clapp, Andrew R. Tee, Mark R. Kelley, Melissa L. Fishel	2021	10
3	The zinc finger/RING domain protein Unkempt regulates cognitive flexibility Scientific Reports ·Elin Vinsland, Pranetha Baskaran, Simeon R. Mihaylov, Carl Hobbs, Hannah M. Wood, Ihssane Bouybayoune, Kriti Shah, Corinne Houart, Andrew R. Tee, Jernej Murn, Cathy Fernandes, J.E. Bateman	2021	7
4	Correction: Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity eLife ·Bernadette Carroll, Dorothea Maetzel, Oliver D.K. Maddocks, Elsje G. Otten, Matthew Ratcliff, Graham R. Smith, Elaine A. Dunlop, João F. Passos, Owen R. Davies, Rudolf Jaenisch, Andrew R. Tee, Sovan Sarkar, Viktor I. Korolchuk	2020	2
5	Distinctive Features of Orbital Adipose Tissue (OAT) in Graves’ Orbitopathy International Journal of Molecular Sciences ·Lei Zhang, Anna Evans, Chris von Ruhland, Mohd Shazli Draman, Sarah Edkins, Amy E. Vincent, Rolando Berlinguer‐Palmini, Aled Rees, Anjana Haridas, Dan Morris, Andrew R. Tee, Marian Ludgate, Douglass M. Turnbull, Fredrik Karpe, Colin Dayan	2020	11
6	Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies Advances in genetics ·Lauren J. McEneaney, Andrew R. Tee	2018	22
7	Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir−bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death Oncogene ·C. E. Johnson, Elaine A. Dunlop, Sara Seifan, Henry D. McCann, Trevor Hay, Geraint J. Parfitt, Ashley T. Jones, Peter Giles, Ming Hong Shen, Julian R. Sampson, Rachel J. Errington, D. M. Davies, Andrew R. Tee	2018	10
8	Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity eLife ·Bernadette Carroll, Dorothea Maetzel, Oliver D.K. Maddocks, Elsje G. Otten, Matthew Ratcliff, Graham R. Smith, Elaine A. Dunlop, João F. Passos, Owen R. Davies, Rudolf Jaenisch, Andrew R. Tee, Sovan Sarkar, Viktor I. Korolchuk	2016	144
9	STAT3 and HIF1α Signaling Drives Oncogenic Cellular Phenotypes in Malignant Peripheral Nerve Sheath Tumors Molecular Cancer Research ·Ellie Rad, Kayleigh Dodd, Laura E. Thomas, Meena Upadhyaya, Andrew R. Tee	2015	23
10	STAT3 and mTOR: co-operating to drive HIF and angiogenesis Oncoscience ·Kayleigh Dodd, Andrew R. Tee	2015	17
11	FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation Autophagy ·Elaine A. Dunlop, Sara Seifan, Tijs Claessens, Christian Behrends, M. A. F. Kamps, Ewelina Rozycka, Alain J. Kemp, Ravi K. Nookala, John Blenis, Barry J. Coull, James T. Murray, Maurice A. M. Van Steensel, Simon Wilkinson, Andrew R. Tee	2014	52
12	mTOR and autophagy: A dynamic relationship governed by nutrients and energy Seminars in Cell and Developmental Biology ·Elaine A. Dunlop, Andrew R. Tee	2014	370
13	Absence of the Birt–Hogg–Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility Oncogene ·Rachael S. Preston, Andrew Philp, Tijs Claessens, Lieke Gijezen, Anders Bondo Dydensborg, Elaine A. Dunlop, Karianne Harper, Tjinta Brinkhuizen, Fred H. Menko, D. M. Davies, Stephen C. Land, Arnim Pause, K. Baar, Maurice A. M. Van Steensel, Andrew R. Tee	2010	50
14	mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action Journal of Biological Chemistry ·Ghada A. Soliman, Hugo A. Acosta-Jaquez, Elaine A. Dunlop, Bilgen Ekim, Nicole E. Maj, Andrew R. Tee, Diane C. Fingar	2009	189
15	Analysis of mTOR signaling by the small G‐proteins, Rheb and RhebL1 FEBS Letters ·Andrew R. Tee, John Blenis, Christopher G. Proud	2005	84
16	mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E Molecular and Cellular Biology ·Diane C. Fingar, Celeste Richardson, Andrew R. Tee, Lynn Cheatham, Christina Tsou, John Blenis Hit paper breakdown →	2003	733
17	Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of Tuberin Journal of Biological Chemistry ·Andrew R. Tee, Rana Anjum, John Blenis	2003	173
18	Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling Proceedings of the National Academy of Sciences ·Andrew R. Tee, Diane C. Fingar, Brendan D. Manning, David J. Kwiatkowski, Lewis C. Cantley, John Blenis Hit paper breakdown →	2002	647
19	Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway Molecular Cell ·Brendan D. Manning, Andrew R. Tee, M. Nicole Logsdon, John Blenis, Lewis C. Cantley Hit paper breakdown →	2002	1281
20	DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling Oncogene ·Andrew R. Tee, Christopher G. Proud	2000	102

About Andrew R. Tee

Andrew R. Tee is a scholar working on Molecular Biology, Physiology, Cell Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 9.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (40 papers), Polyamine Metabolism and Applications (21 papers), Tuberous Sclerosis Complex Research (17 papers), Autophagy in Disease and Therapy (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Renal cell carcinoma treatment (6 papers), Microtubule and mitosis dynamics (5 papers) and Mast cells and histamine (5 papers). The work is most often cited by research in Molecular Biology (6.6k citations), Aging (139 citations), Cell Biology (1.3k citations), Cancer Research (970 citations) and Physiology (1.5k citations). Andrew R. Tee has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include John Blenis, Lewis C. Cantley, Brendan D. Manning, Elaine A. Dunlop, Christopher G. Proud, Diane C. Fingar, Stephen C. Land, Kayleigh Dodd, Philippe P. Roux and Lynn Cheatham. Their work appears in journals such as Journal of Biological Chemistry, Seminars in Cell and Developmental Biology, Oncogene, Cancers and Cellular Signalling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact